Transparency at Bristol-Myers Squibb
We believe in providing an open environment to help build a foundation of trust and respect among our colleagues, health care professionals, patients, stockholders and the public. We operate our business with high standards of business integrity and ethics; complying with the letter and spirit of current laws and regulations. We strongly believe in the importance of making information about our medicines available as we continue to seek a better understanding of the needs of our patients and customers. We are committed to disclosing information about our business in the following areas:
As a company, we are dedicated to educating our patients, medical/research communities, the media, policy makers and the general public. We believe in the integrity of the information we collect and are committed to communicating our data.
We address areas of community and unmet medical need through a variety of grant-making programs, each with its own focus. We are committed to making information about our giving and grant-making available to the public.
To keep the public up to date on our investigational compounds, we share information on select compounds by providing this data as it becomes available.
As active participants in providing health care access to patients, we support and contribute to the state and local candidates and political organizations that support our views on health care issues affecting the industry, when permitted by law. A list of all U.S. contributions made by Bristol-Myers Squibb and the Employee Political Action Committee is available.
We conduct our business to help patients prevail over serious diseases in a manner that contributes to economic growth, social responsibility and a healthy environment now and in the future. Our Company progress is available, along with other important information.
NOTE: Bristol-Myers Squibb complies with financial reporting requirements regarding payments made to health care providers as required by various state laws in the United States. Bristol-Myers Squibb will timely report additional required information as new disclosure requirements are enacted under local or national law. Additionally, Bristol-Myers Squibb will be expanding the website to include additional content regarding payments made to U.S. health care providers in advance of the reporting requirements under the Patient Protection and Affordable Care Act.